Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Real-World Study EvalUating the EffectiveNess and Safety of RISankizumab in PatiEnts With Ulcerative Colitis (SUNRISE-UC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06764706
Title field or adapter rule
{'original_value': 'A Prospective, Real-World Study EvalUating the EffectiveNess and Safety of RISankizumab in PatiEnts With Ulcerative Colitis (SUNRISE-UC)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:36.566490+00:00
Published At
2026-10-22T00:00:00+00:00
Record Updated At
2026-10-22
Source Retrieved At
2026-10-31T22:18:58.295941+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ulcerative Colitis"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-22", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06764706"
protocolSection.identificationModule.officialTitle
"A Prospective, Real-World Study EvalUating the EffectiveNess and Safety of RISankizumab in PatiEnts With Ulcerative Colitis (SUNRISE-UC)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
null
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Ulcerative Colitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.